Alphatec Holdings (ATEC) Gets a Buy from Canaccord Genuity
Canaccord Genuity analyst Caitlin Cronin maintained a Buy rating on Alphatec Holdings on December 16 and set a price target of $25.00.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
According to TipRanks, Cronin is a 4-star analyst with an average return of 15.2% and a 56.25% success rate. Cronin covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Vericel, and Enovis.
In addition to Canaccord Genuity, Alphatec Holdings also received a Buy from Wells Fargo’s Vik Chopra in a report issued on December 12. However, on December 9, TR | OpenAI – 4o reiterated a Hold rating on Alphatec Holdings (NASDAQ: ATEC).
Based on Alphatec Holdings’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $196.5 million and a GAAP net loss of $28.58 million. In comparison, last year the company earned a revenue of $150.72 million and had a GAAP net loss of $39.62 million
Based on the recent corporate insider activity of 90 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ATEC in relation to earlier this year. Earlier this month, Craig Hunsaker, the EVP, PEOPLE & CULTURE of ATEC sold 32,584.00 shares for a total of $679,050.56.
Read More on ATEC:
